<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="61974">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01768936</url>
  </required_header>
  <id_info>
    <org_study_id>TUM-PCT-1</org_study_id>
    <secondary_id>PCTRatio Reevaluation</secondary_id>
    <nct_id>NCT01768936</nct_id>
  </id_info>
  <brief_title>Procalcitonin Ratio's Impact on the Decision Upon On-demand Relaparotomy in Septic Peritonitis</brief_title>
  <official_title>Procalcitonin Ratio's Impact on the Decision Upon On-demand Relaparotomy in Septic Peritonitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHIR-Net</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHIR-Net</source>
  <oversight_info>
    <authority>Ethics Commission: TUM</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Procalcitonin (PCT) serum levels are monitored in patients with secondary peritonitis after
      initial operative focus elimination to investigate the PCT ratio's impact on decision-making
      for or against early relaparotomy in the on-demand relaparotomy concept of secondary septic
      peritonitis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>prediction of focus elimination: cured patients versus patients with persisting peritonitis (definitions see below)</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 21 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>definition of 'focus elimination': patients with intestinal perforation or anastomotic leakage develop (local) peritonitis and consecutive abdominal sepsis. These patients need surgical intervention for focus elimination. This operative intervention aims to eradicate all infectious material and is intended to remove the leaking intestinal lesion. Whether this focus is eliminated or not can be controlled by either planned relaparotomy (normally within 48h after the first operation) or on demand relaparotomy in case of clinical deterioration. The focus can be assumed to be eliminated in all cases where either relaparotomy reveals no ongoing infection or persisting focus and whenever a patient recovers rapidly after initial surgery.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">234</enrollment>
  <condition>Secondary Peritonitis After Intestinal Perforation</condition>
  <arm_group>
    <arm_group_label>eliminated infectious abdominal focus</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>persisting/progressing infectious abdominal focus</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        consecutive postoperative surgical patients on ICU after intestinal perforation or
        anastomotic leakage with indication for surgical focus elimination
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;18 years

          -  necessity for operative intervention to eliminate an infectious peritoneal /
             abdominal focus after organ perforation

          -  abdominal sepsis according to the American College of Chest Physicians/Society of
             Critical Care Medicine Consensus Conference definition

        Exclusion Criteria:

          -  pregnancy

          -  immunosuppressive medication
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Klinikum rechts der Isar der TU MÃ¼nchen</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 15, 2013</lastchanged_date>
  <firstreceived_date>January 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>on-demand relaparotomy</keyword>
  <keyword>PCT</keyword>
  <keyword>procalcitonin</keyword>
  <keyword>peritonitis</keyword>
  <keyword>sepsis</keyword>
  <keyword>focus index</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Intestinal Perforation</mesh_term>
    <mesh_term>Peritonitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
